Results 91 to 95 of about 178 (95)

Interleukin-6 receptor inhibitor levilimab in the treatment of COVID-19 in patients with chronic kidney disease

Nephrology, 2023
Kim I.G. Kim, Frolov M.A. Frolov, Terentyeva N.V. Terentyeva, Sysoeva I.L. Sysoeva, Dyakova E.N. Dyakova, Usatyuk S.S. Usatyuk, Tomilina N.A. Tomilina, Frolova N.F. Frolova   +7 more
openaire   +1 more source

Comparative investigation of the efficacy of Cortexin®, Pineamine®, levilimab, adalimumab, and dexamethasone on cytokine storm models

Farmaciya (Pharmacy), 2021
A.V. Kalatanova, E.I. Trofimets, A.N. Afanasieva, V.B. Saparova, K.L. Kryshen, I.E. Makarenko   +5 more
openaire   +1 more source

AQUEOUS PHARMACEUTICAL COMPOSITION OF LEVILIMAB

2021
TOLSTYKH DMITRII ALEKSANDROVICH, TSUKUR ALINA ALEKSANDROVNA, LOMKOVA EKATERINA ALEKSANDROVNA, IAKOVLEV ALEKSANDR OLEGOVICH, LUTCKII ANTON ALEKSANDROVICH, LINKOVA IULIIA NIKOLAEVNA, ZINKINA-ORIKHAN ARINA VALEREVNA, MOROZOV DMITRY VALENTINOVICH   +7 more
openaire   +1 more source

Levilimab – an advanced solution for the treatment of rheumatoid arthritis

Pharmateca
Klimenko A.A. Klimenko, Kondrashov A.A. Kondrashov, Andriyashkina D.Yu. Andriyashkina   +2 more
openaire   +1 more source

Clinical and laboratory efficacy of levilimab therapy in patients with rheumatoid arthritis in real-world clinical practice

Therapy
K.P. Morozova Morozova, D.B. Aliev Aliev, A.L. Chudinov Chudinov, R.R. Samigullina Samigullina, O.V. Inamova Inamova, E.A. Trofimov Trofimov, E.S. Melnikov Melnikov, V.I. Mazurov Mazurov   +7 more
openaire   +1 more source